NKTR logo

Nektar Therapeutics (NKTR) Operating Margin

Annual Operating Margin:

-131.99%+18.06%(+12.04%)
December 31, 2024

Summary

  • As of today, NKTR annual operating profit margin is -131.99%, with the most recent change of +18.06% (+12.04%) on December 31, 2024.
  • During the last 3 years, NKTR annual operating margin has risen by +305.77% (+69.85%).
  • NKTR annual operating margin is now -328.95% below its all-time high of 57.65%, reached on December 31, 2018.

Performance

NKTR Operating Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNKTRprofitability metrics

Quarterly Operating Margin:

-320.21%+103.94%(+24.51%)
June 30, 2025

Summary

  • As of today, NKTR quarterly operating profit margin is -320.21%, with the most recent change of +103.94% (+24.51%) on June 30, 2025.
  • Over the past year, NKTR quarterly operating margin has dropped by -164.88% (-106.15%).
  • NKTR quarterly operating margin is now -457.74% below its all-time high of 89.51%, reached on June 30, 2018.

Performance

NKTR Quarterly Operating Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNKTRprofitability metrics

Operating Margin Formula

Operating Profit Margin =  Operating Profit
Revenue
✕ 100%

NKTR Operating Margin Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+12.0%-106.2%
3Y3 Years+69.8%-47.7%
5Y5 Years+65.6%-101.3%

NKTR Operating Margin Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+69.8%-278.5%+24.5%
5Y5-Yearat high+69.8%-278.5%+32.1%
All-TimeAll-Time-328.9%+69.8%-457.7%+33.3%

NKTR Operating Margin History

DateAnnualQuarterly
Jun 2025
-
-320.21%(+24.5%)
Mar 2025
-
-424.15%(-401.4%)
Dec 2024
-131.99%(+12.0%)
-84.60%(+40.5%)
Sep 2024
-
-142.18%(+8.5%)
Jun 2024
-
-155.33%(+2.4%)
Mar 2024
-
-159.21%(-24.0%)
Dec 2023
-150.05%(+42.5%)
-128.37%(+7.5%)
Sep 2023
-
-138.77%(+16.4%)
Jun 2023
-
-166.08%(+3.1%)
Mar 2023
-
-171.42%(+7.7%)
Dec 2022
-260.97%(+40.4%)
-185.67%(-17.1%)
Sep 2022
-
-158.61%(+26.8%)
Jun 2022
-
-216.78%(+53.2%)
Mar 2022
-
-463.64%(-2.7%)
Dec 2021
-437.76%(-76.2%)
-451.48%(+1.0%)
Sep 2021
-
-455.82%(-17.2%)
Jun 2021
-
-389.00%(+15.9%)
Mar 2021
-
-462.60%(+2.0%)
Dec 2020
-248.45%(+35.3%)
-471.92%(-37.5%)
Sep 2020
-
-343.12%(-115.7%)
Jun 2020
-
-159.09%(+9.0%)
Mar 2020
-
-174.88%(+46.0%)
Dec 2019
-383.92%(-765.9%)
-323.78%(+4.2%)
Sep 2019
-
-337.94%(+29.0%)
Jun 2019
-
-475.96%(-11.3%)
Mar 2019
-
-427.63%(-69.8%)
Dec 2018
57.65%(+506.3%)
-251.83%(+29.1%)
Sep 2018
-
-355.28%(-496.9%)
Jun 2018
-
89.51%(+139.2%)
Mar 2018
-
-228.15%(-2603.2%)
Dec 2017
-14.19%(+79.2%)
-8.44%(-118.6%)
Sep 2017
-
45.44%(+134.2%)
Jun 2017
-
-132.86%(+39.6%)
Mar 2017
-
-220.14%(-156.5%)
Dec 2016
-68.22%(-435.9%)
-85.83%(+5.2%)
Sep 2016
-
-90.55%(+22.6%)
Jun 2016
-
-116.96%(-626.0%)
Mar 2016
-
-16.11%(+75.9%)
Dec 2015
-12.73%(-55.1%)
-66.96%(-9665.7%)
Sep 2015
-
0.70%(+100.4%)
Jun 2015
-
-191.82%(-584.9%)
Mar 2015
-
39.56%(+120.6%)
Dec 2014
-8.21%(+89.8%)
-191.74%(-417.2%)
Sep 2014
-
60.45%(+175.2%)
Jun 2014
-
-80.37%(+56.3%)
Mar 2014
-
-184.12%(-133.2%)
Dec 2013
-80.67%(+53.1%)
-78.96%(-637.3%)
Sep 2013
-
-10.71%(+88.9%)
Jun 2013
-
-96.29%(+51.2%)
Mar 2013
-
-197.37%(+3.8%)
Dec 2012
-171.85%(+0.9%)
-205.15%(-14.8%)
Sep 2012
-
-178.69%(-56.8%)
Jun 2012
-
-113.95%(+43.6%)
Mar 2012
-
-202.00%(+7.5%)
Dec 2011
-173.39%(-1658.5%)
-218.40%(-177.1%)
Sep 2011
-
-78.83%(+60.1%)
Jun 2011
-
-197.70%(+34.0%)
Mar 2011
-
-299.73%(-1605.9%)
Dec 2010
-9.86%(+92.5%)
-17.57%(-7.1%)
Sep 2010
-
-16.41%(-473.8%)
Jun 2010
-
4.39%(+143.5%)
Mar 2010
-
-10.10%(+28.3%)
Dec 2009
-132.25%
-14.09%(+95.0%)
DateAnnualQuarterly
Sep 2009
-
-282.29%(-20.3%)
Jun 2009
-
-234.68%(+24.8%)
Mar 2009
-
-312.00%(-116.0%)
Dec 2008
-90.03%(-580.0%)
-144.46%(+10.4%)
Sep 2008
-
-161.21%(+1.4%)
Jun 2008
-
-163.51%(+22.0%)
Mar 2008
-
-209.53%(-1066.0%)
Dec 2007
-13.24%(+81.9%)
-17.97%(+48.3%)
Sep 2007
-
-34.75%(-9.7%)
Jun 2007
-
-31.68%(-3.7%)
Mar 2007
-
-30.55%(+33.1%)
Dec 2006
-73.14%(+47.2%)
-45.65%(-18.0%)
Sep 2006
-
-38.69%(+48.8%)
Jun 2006
-
-75.56%(+34.0%)
Mar 2006
-
-114.56%(-6.0%)
Dec 2005
-138.40%(-113.9%)
-108.04%(-68.1%)
Sep 2005
-
-64.28%(+30.6%)
Jun 2005
-
-92.64%(-9.6%)
Mar 2005
-
-84.55%(-44.1%)
Dec 2004
-64.71%(-3.9%)
-58.66%(+12.0%)
Sep 2004
-
-66.69%(+9.9%)
Jun 2004
-
-74.02%(+2.7%)
Mar 2004
-
-76.07%(+2.1%)
Dec 2003
-62.29%(+41.0%)
-77.70%(-50.4%)
Sep 2003
-
-51.66%(+1.8%)
Jun 2003
-
-52.63%(+23.4%)
Mar 2003
-
-68.71%(+41.6%)
Dec 2002
-105.52%(+26.2%)
-117.74%(-11.2%)
Sep 2002
-
-105.88%(-3.9%)
Jun 2002
-
-101.91%(-15.6%)
Mar 2002
-
-88.16%(+53.1%)
Dec 2001
-142.90%(-15.5%)
-188.08%(-47.9%)
Sep 2001
-
-127.16%(+18.3%)
Jun 2001
-
-155.58%(+5.8%)
Mar 2001
-
-165.08%(-21.7%)
Dec 2000
-123.67%(-67.2%)
-135.68%(-19.7%)
Sep 2000
-
-113.35%(-2.1%)
Jun 2000
-
-110.97%(+20.1%)
Mar 2000
-
-138.92%(-79.9%)
Dec 1999
-73.97%(+26.7%)
-77.20%(-7.5%)
Sep 1999
-
-71.82%(-6.4%)
Jun 1999
-
-67.52%(+15.3%)
Mar 1999
-
-79.69%(+25.9%)
Dec 1998
-100.89%(-19.5%)
-107.49%(+10.7%)
Sep 1998
-
-120.36%(-101.4%)
Jun 1998
-
-59.75%(+56.2%)
Mar 1998
-
-136.53%(-52.1%)
Dec 1997
-84.46%(+49.3%)
-89.75%(-11.7%)
Sep 1997
-
-80.37%(-0.2%)
Jun 1997
-
-80.24%(+7.1%)
Mar 1997
-
-86.37%(+50.0%)
Dec 1996
-166.67%(+35.6%)
-172.73%(-15.2%)
Sep 1996
-
-150.00%(+30.0%)
Jun 1996
-
-214.29%(-53.1%)
Mar 1996
-
-140.00%(+55.2%)
Dec 1995
-258.82%(+22.8%)
-312.50%(-56.3%)
Sep 1995
-
-200.00%(0.0%)
Jun 1995
-
-200.00%(+47.8%)
Mar 1995
-
-383.33%(+20.1%)
Dec 1994
-335.29%
-480.00%(-161.8%)
Sep 1994
-
-183.33%(+50.0%)
Jun 1994
-
-366.67%(-46.7%)
Mar 1994
-
-250.00%

FAQ

  • What is Nektar Therapeutics annual operating profit margin?
  • What is the all-time high annual operating margin for Nektar Therapeutics?
  • What is Nektar Therapeutics annual operating margin year-on-year change?
  • What is Nektar Therapeutics quarterly operating profit margin?
  • What is the all-time high quarterly operating margin for Nektar Therapeutics?
  • What is Nektar Therapeutics quarterly operating margin year-on-year change?

What is Nektar Therapeutics annual operating profit margin?

The current annual operating margin of NKTR is -131.99%

What is the all-time high annual operating margin for Nektar Therapeutics?

Nektar Therapeutics all-time high annual operating profit margin is 57.65%

What is Nektar Therapeutics annual operating margin year-on-year change?

Over the past year, NKTR annual operating profit margin has changed by +18.06% (+12.04%)

What is Nektar Therapeutics quarterly operating profit margin?

The current quarterly operating margin of NKTR is -320.21%

What is the all-time high quarterly operating margin for Nektar Therapeutics?

Nektar Therapeutics all-time high quarterly operating profit margin is 89.51%

What is Nektar Therapeutics quarterly operating margin year-on-year change?

Over the past year, NKTR quarterly operating profit margin has changed by -164.88% (-106.15%)
On this page